




 



 News provided byNov 20, 2017, 10:00 ET Share this articleHERTFORDSHIRE, England and PITTSBURGH, Nov. 20, 2017 /PRNewswire/ --Â Mylan N.V. (NASDAQ, TASE: MYL) today announced that its president, Rajiv Malik, will present at the Evercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference in Boston, Mass., on Thursday, Nov. 30, 2017, at 3:50 p.m. ET. The discussion will focus on Mylan's robust pipeline and current dynamics in the generics industry.Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's website at investor.mylan.com. An archived version also will be available following the live presentation and can be accessed at the same location for a limited time.Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com. We routinely post information that may be important to investors on our website at investor.mylan.com.View original content with multimedia:http://www.prnewswire.com/news-releases/mylan-to-present-at-evercore-isi-inaugural-biopharma-catalystdeep-dive-conference-300559359.htmlSOURCE Mylan N.V.
http://www.mylan.com
Nov 13, 2017, 09:28 ETPreview: Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease More news releases in similar topics You just read: News provided byNov 20, 2017, 10:00 ET Share this articleTake advantage of the world's leading distribution platform.Request more informationHave an account? Log InPhone 8AM - 10PM ET+1-888-776-0942Searching for your content... Share this articlePhone 888-776-0942 from 8 AM - 10 PM ETChat